All lobbying filings
THEGROUP DC, LLC
THEGROUP DC, LLC filed a Q4 report for ASTELLAS PHARMA US, INC on January 20, 2026, reporting $70,000 in lobbying income.
Lobbying for ASTELLAS PHARMA US, INC · Pharmaceutical research and manufacturing company.
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$70,000
What the client paid this registrant for the period.
Client based in
Illinois
Government bodies contacted
2
Lobbying activity
2
H.R. 1300, PSA Screening for HIM Act Prostate-Specific Antigen Screening for High-risk Insured Men Act Issues related to the treatment of menopause and womens health at mid-life.
H.R. 1300, PSA Screening for HIM Act Prostate-Specific Antigen Screening for High-risk Insured Men Act Issues related to the treatment of menopause and womens health at mid-life.
Bills named in this filing
1